Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 3/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 2/20 | 0.50 |
| ▸ | BCHE | P06276 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | BACE1 | P56817 | 1/20 | 0.50 |
| ▸ | DRD2 | P14416 | 1/20 | 0.49 |
| ▸ | HTR2A | P28223 | 1/20 | 0.49 |
| ▸ | HTR2C | P28335 | 1/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | CCR3 | P51677 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL994346 | 1.00 | CYP2D6 (0.66) | CYP2D6CYP3A4ALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL2227086 | 1.00 | CYP2D6 (0.66) | CYP2D6CYP3A4ALDH1A1CYP1A2CYP2C19 | |
| Hydrochloric Acid SCHEMBL5266699 | 0.98 | CYP2D6 (0.64) | CYP2D6CYP3A4ALDH1A1CYP1A2CYP2C19 | |
| Hydrochloric Acid SCHEMBL5266695 | 0.98 | CYP2D6 (0.64) | CYP2D6CYP3A4ALDH1A1CYP1A2CYP2C19 | |
| Hydrochloric Acid SCHEMBL16333750 | 0.98 | CYP2D6 (0.64) | CYP2D6CYP3A4ALDH1A1CYP1A2CYP2C19 | |
| Methane SCHEMBL692994 | 0.98 | CYP2D6 (0.64) | CYP2D6CYP3A4ALDH1A1CYP1A2CYP2C19 | |
| Hydrochloric Acid SCHEMBL4221752 | 0.98 | CYP2D6 (0.64) | CYP2D6CYP3A4ALDH1A1CYP1A2CYP2C19 | |
| Hydrochloric Acid SCHEMBL16333749 | 0.98 | CYP2D6 (0.64) | CYP2D6CYP3A4ALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL556001 | 0.95 | CYP2D6 (0.59) | CYP2D6CYP3A4ALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL3459933 | 0.95 | CYP2D6 (0.59) | CYP2D6CYP3A4ALDH1A1CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-7330732-A | — | — | None | — | — | JP | disclosed |
| US-11236122-B2 | Triterpene amine derivatives | DFH THERAPEUTICS (US) | 2022-02-01 | — | — | US | disclosed |
| US-20210253627-A1 | TRITERPENE AMINE DERIVATIVES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2021-08-19 | — | — | US | disclosed |
| WO-2021000785-A1 | PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS SELECTIVE INHIBITORS OF JANUS KINASE 1 | 深圳美莹基因科技有限公司 | 2021-01-07 | — | — | WO | disclosed |
| CN-112174951-A | Pyrrolo [2, 3-b ] pyridine derivatives as selective inhibitors of janus kinase 1 | 深圳美莹基因科技有限公司 | 2021-01-05 | — | — | CN | disclosed |
| EP-2897940-B1 | HETEROCYCLIC COMPOUNDS, MEDICAMENTS CONTAINING SAID COMPOUNDS, USE THEREOF AND PROCESSES FOR THE PREPARATION THEREOF | BOEHRINGER INGELHEIM INT (DE) | 2019-05-01 | — | — | EP | disclosed |
| US-10207993-B2 | Compounds as anti-tubercular agents | SPHAERA PHARMA PVT. LTD. (IN) | 2019-02-19 | — | — | US | disclosed |
| CN-108975292-A | A kind of preparation method of double fluorine sulfonyl imide compounds | 九江天赐高新材料有限公司 | 2018-12-11 | — | — | CN | disclosed |
| EP-2584903-B1 | NOVEL HETEROCYCLIC COMPOUNDS AS ERK INHIBITORS | MERCK SHARP & DOHME (US) | 2018-10-24 | — | — | EP | disclosed |
| US-20170334851-A1 | NOVEL COMPOUNDS AS ANTI-TUBERCULAR AGENTS | SPHAERA PHARMA PVT. LTD. (IN) | 2017-11-23 | — | — | US | disclosed |
| US-7642265-B2 | Benzimidazoles and analogs thereof as antivirals | ISIS PHARMACEUTICALS, INC. (US) | 2010-01-05 | — | — | US | disclosed |
| EP-2123769-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE 3-AMINOPIPERIDINE OR SALT THEREOF | Kaneka Corporation (JP) | 2009-11-25 | — | — | EP | disclosed |
| US-20080045536-A1 | FUSED HETEROCYCLIC COMPOUNDS USEFUL AS KINASE MODULATORS | BRISTOL-MYERS SQUIBB COMPANY | 2008-02-21 | — | — | US | disclosed |
| US-7094791-B2 | Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof | AVALON PHARMACEUTICALS, INC. (US) | 2006-08-22 | — | — | US | disclosed |
| WO-2005011675-A1 | DERIVATIVES OF 3-HYDROXY-PYRROLE-2,4-DICARBOXYLIC ACID AND USES THEREOF | AVALON PHARMACEUTICALS (US) | 2005-02-10 | — | — | WO | disclosed |
| US-20050026991-A1 | Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof | CLINICAL DATA, INC. | 2005-02-03 | — | — | US | disclosed |
| EP-0719772-B1 | OPTICALLY ACTIVE IMIDAZOLIDINONE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | KYORIN SEIYAKU KK (JP) | 2000-07-12 | — | — | EP | disclosed |
| US-5726188-A | TREATING SENILE DEMENTIA | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 1998-03-10 | — | — | US | disclosed |
| EP-0719772-A1 | OPTICALLY ACTIVE IMIDAZOLIDINONE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 1996-07-03 | — | — | EP | disclosed |
| JP-H07330732-A | OPTICALLY ACTIVE 3-AMINO-1-BENZYLPIPERIDINE DERIVATIVE | KYORIN PHARMACEUT CO LTD | 1995-12-19 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210253627-A1 | TRITERPENE AMINE DERIVATIVES | BET1, PGGT1B, NFATC1 | CYP2D6 1253/4885CYP3A4 521/4885ALDH1A1 3332/4885 |
| US-10207993-B2 | Compounds as anti-tubercular agents | FNTB, G6PD, PGGT1B | CYP2D6 865/4885CYP3A4 527/4885ALDH1A1 193/4885 |
| US-20170334851-A1 | NOVEL COMPOUNDS AS ANTI-TUBERCULAR AGENTS | FNTB, PGGT1B, GGPS1 | CYP2D6 1722/4885CYP3A4 1284/4885ALDH1A1 467/4885 |
| US-20080045536-A1 | FUSED HETEROCYCLIC COMPOUNDS USEFUL AS KINASE MODULATORS | MAP3K3, MAP3K2, MAP4K3 | CYP2D6 2839/4885CYP3A4 2545/4885ALDH1A1 4291/4885 |
| US-20050026991-A1 | Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof | HPGDS, PHGDH, PDHA2 | CYP2D6 2485/4885CYP3A4 3172/4885ALDH1A1 302/4885 |
| US-11236122-B2 | Triterpene amine derivatives | BET1, PGGT1B, NFATC1 | CYP2D6 1253/4885CYP3A4 521/4885ALDH1A1 3332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.